These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 20574716)

  • 1. Diagnosis and high incidence of hyperornithinemia-hyperammonemia-homocitrullinemia (HHH) syndrome in northern Saskatchewan.
    Sokoro AA; Lepage J; Antonishyn N; McDonald R; Rockman-Greenberg C; Irvine J; Lehotay DC
    J Inherit Metab Dis; 2010 Dec; 33 Suppl 3():S275-81. PubMed ID: 20574716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperornithinemia-hyperammonemia-homocitrullinuria (HHH) syndrome in adulthood: a rare recognizable condition.
    Filosto M; Alberici A; Tessa A; Padovani A; Santorelli FM
    Neurol Sci; 2013 Sep; 34(9):1699-701. PubMed ID: 23247599
    [No Abstract]   [Full Text] [Related]  

  • 3. CUGC for hyperornithinemia-hyperammonemia-homocitrullinuria (HHH) syndrome.
    Martinelli D; Fiermonte G; Häberle J; Boenzi S; Goffredo BM; Travaglini L; Agolini E; Porcelli V; Dionisi-Vici C
    Eur J Hum Genet; 2020 Jul; 28(7):982-987. PubMed ID: 32242103
    [No Abstract]   [Full Text] [Related]  

  • 4. The hyperornithinemia-hyperammonemia-homocitrullinuria syndrome.
    Martinelli D; Diodato D; Ponzi E; Monné M; Boenzi S; Bertini E; Fiermonte G; Dionisi-Vici C
    Orphanet J Rare Dis; 2015 Mar; 10():29. PubMed ID: 25874378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow-up of four patients affected by HHH syndrome.
    Kim SZ; Song WJ; Nyhan WL; Ficicioglu C; Mandell R; Shih VE
    Clin Chim Acta; 2012 Jul; 413(13-14):1151-5. PubMed ID: 22465082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of novel mutations in the SLC25A15 gene in hyperornithinemia-hyperammonemia-homocitrullinuria (HHH) syndrome: a clinical, molecular, and functional study.
    Tessa A; Fiermonte G; Dionisi-Vici C; Paradies E; Baumgartner MR; Chien YH; Loguercio C; de Baulny HO; Nassogne MC; Schiff M; Deodato F; Parenti G; Rutledge SL; Vilaseca MA; Melone MA; Scarano G; Aldamiz-Echevarría L; Besley G; Walter J; Martinez-Hernandez E; Hernandez JM; Pierri CL; Palmieri F; Santorelli FM
    Hum Mutat; 2009 May; 30(5):741-8. PubMed ID: 19242930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical diagnosis and treatment of three cases with hyperornithinemia-hyperammonemia-homocitrullinuria syndrome].
    Guan HZ; Ding Y; Li DX; Dong H; Song JQ; Jin Y; Zhu ZJ; Sun LY; Yang YL
    Zhonghua Er Ke Za Zhi; 2017 Jun; 55(6):428-433. PubMed ID: 28592010
    [No Abstract]   [Full Text] [Related]  

  • 8. Insights into the mutation-induced HHH syndrome from modeling human mitochondrial ornithine transporter-1.
    Wang JF; Chou KC
    PLoS One; 2012; 7(1):e31048. PubMed ID: 22292090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune Alterations in a Patient With Hyperornithinemia-Hyperammonemia-Homocitrullinuria Syndrome: A Case Report.
    Silvera-Ruiz SM; Gemperle C; Peano N; Olivero V; Becerra A; Häberle J; Gruppi A; Larovere LE; Motrich RD
    Front Immunol; 2022; 13():861516. PubMed ID: 35711415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Milder Form of Urea Cycle Defect Revisited: Report and Review of Hyperornithinaemia-Hyperammonaemia-Homocitrullinuria (HHH) Syndrome Diagnosed in a Teenage Girl Presenting with Recurrent Encephalopathy.
    Qadri SK; Ting TW; Lim JS; Jamuar SS
    Ann Acad Med Singap; 2016 Dec; 45(12):563-566. PubMed ID: 28062886
    [No Abstract]   [Full Text] [Related]  

  • 11. Lactate/pyruvate in hyperornithinemia-hyperammonemia-homocitrullinuria syndrome.
    Ono H; Tamada T; Shigematsu Y
    Pediatr Int; 2018 Aug; 60(8):762-764. PubMed ID: 30058227
    [No Abstract]   [Full Text] [Related]  

  • 12. Pathogenic potential of SLC25A15 mutations assessed by transport assays and complementation of Saccharomyces cerevisiae ORT1 null mutant.
    Marobbio CM; Punzi G; Pierri CL; Palmieri L; Calvello R; Panaro MA; Palmieri F
    Mol Genet Metab; 2015 May; 115(1):27-32. PubMed ID: 25818551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperornithinaemia-hyperammonaemia-homocitrullinuria syndrome: a treatable genetic liver disease warranting urgent diagnosis.
    Lee HH; Poon KH; Lai CK; Au KM; Siu TS; Lai JP; Mak CM; Yuen YP; Lam CW; Chan AY
    Hong Kong Med J; 2014 Feb; 20(1):63-6. PubMed ID: 24473688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel mutation in the SLC25A15 gene in a Turkish patient with HHH syndrome: functional analysis of the mutant protein.
    Ersoy Tunalı N; Marobbio CM; Tiryakioğlu NO; Punzi G; Saygılı SK; Onal H; Palmieri F
    Mol Genet Metab; 2014 May; 112(1):25-9. PubMed ID: 24721342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic variability among patients with hyperornithinaemia-hyperammonaemia-homocitrullinuria syndrome homozygous for the delF188 mutation in SLC25A15.
    Debray FG; Lambert M; Lemieux B; Soucy JF; Drouin R; Fenyves D; Dubé J; Maranda B; Laframboise R; Mitchell GA
    J Med Genet; 2008 Nov; 45(11):759-64. PubMed ID: 18978333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cloning and characterization of human ORNT2: a second mitochondrial ornithine transporter that can rescue a defective ORNT1 in patients with the hyperornithinemia-hyperammonemia-homocitrullinuria syndrome, a urea cycle disorder.
    Camacho JA; Rioseco-Camacho N; Andrade D; Porter J; Kong J
    Mol Genet Metab; 2003 Aug; 79(4):257-71. PubMed ID: 12948741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and functional characterization of a human ORNT1 mutation (T32R) in the hyperornithinemia-hyperammonemia-homocitrullinuria (HHH) syndrome.
    Camacho JA; Mardach R; Rioseco-Camacho N; Ruiz-Pesini E; Derbeneva O; Andrade D; Zaldivar F; Qu Y; Cederbaum SD
    Pediatr Res; 2006 Oct; 60(4):423-9. PubMed ID: 16940241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome with stroke-like imaging presentation: clinical, biochemical and molecular analysis.
    Al-Hassnan ZN; Rashed MS; Al-Dirbashi OY; Patay Z; Rahbeeni Z; Abu-Amero KK
    J Neurol Sci; 2008 Jan; 264(1-2):187-94. PubMed ID: 17825324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome (HHH) presenting with acute fulminant hepatic failure.
    Mhanni AA; Chan A; Collison M; Seifert B; Lehotay DC; Sokoro A; Huynh HQ; Greenberg CR
    J Pediatr Gastroenterol Nutr; 2008 Mar; 46(3):312-5. PubMed ID: 18376250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperornithinemia, hyperammonemia, and homocitrullinuria syndrome with evidence of mitochondrial dysfunction due to a novel SLC25A15 (ORNT1) gene mutation in a Palestinian family.
    Korman SH; Kanazawa N; Abu-Libdeh B; Gutman A; Tsujino S
    J Neurol Sci; 2004 Mar; 218(1-2):53-8. PubMed ID: 14759633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.